IRIS
BARICICH, Alessio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.537
NA - Nord America 3.977
AS - Asia 2.726
SA - Sud America 462
Continente sconosciuto - Info sul continente non disponibili 218
AF - Africa 137
OC - Oceania 15
Totale 12.072
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.816
RU - Federazione Russa 1.102
IE - Irlanda 827
SG - Singapore 820
IT - Italia 682
CN - Cina 581
FR - Francia 453
HK - Hong Kong 408
DE - Germania 400
SE - Svezia 380
VN - Vietnam 352
BR - Brasile 333
UA - Ucraina 241
IN - India 127
GB - Regno Unito 122
FI - Finlandia 115
CA - Canada 100
KR - Corea 65
BD - Bangladesh 56
AR - Argentina 51
JP - Giappone 49
ID - Indonesia 47
IR - Iran 47
BJ - Benin 41
NL - Olanda 38
ES - Italia 32
ZA - Sudafrica 31
TR - Turchia 30
MX - Messico 29
PL - Polonia 25
BE - Belgio 24
CZ - Repubblica Ceca 24
IQ - Iraq 24
EG - Egitto 23
EC - Ecuador 22
PK - Pakistan 19
AT - Austria 17
MY - Malesia 16
AU - Australia 15
PE - Perù 13
PH - Filippine 12
CL - Cile 11
KE - Kenya 11
LT - Lituania 10
PY - Paraguay 10
TW - Taiwan 10
UZ - Uzbekistan 9
VE - Venezuela 9
JO - Giordania 8
SA - Arabia Saudita 8
TH - Thailandia 8
DZ - Algeria 7
NG - Nigeria 7
RS - Serbia 7
CH - Svizzera 6
JM - Giamaica 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
CO - Colombia 4
GT - Guatemala 4
MA - Marocco 4
MD - Moldavia 4
MO - Macao, regione amministrativa speciale della Cina 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BS - Bahamas 3
GR - Grecia 3
KZ - Kazakistan 3
LV - Lettonia 3
MK - Macedonia 3
NI - Nicaragua 3
OM - Oman 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
UY - Uruguay 3
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
EU - Europa 2
GY - Guiana 2
KH - Cambogia 2
LB - Libano 2
LI - Liechtenstein 2
SV - El Salvador 2
AL - Albania 1
BM - Bermuda 1
BN - Brunei Darussalam 1
CG - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GF - Guiana Francese 1
GM - Gambi 1
HN - Honduras 1
HT - Haiti 1
Totale 11.843
Salva come PNG Salva come JPEG
Città #
Dublin 819
Jacksonville 393
Hong Kong 391
San Jose 366
Singapore 333
Council Bluffs 294
Ashburn 262
Beijing 178
Dearborn 168
Chandler 161
Los Angeles 121
Wilmington 117
Columbus 116
Lauterbourg 113
Moscow 112
Ho Chi Minh City 105
Princeton 99
Lawrence 98
Ann Arbor 87
Hanoi 73
Piemonte 70
New York 68
Buffalo 67
San Mateo 67
Seoul 52
Novara 47
Munich 44
Santa Clara 44
São Paulo 44
Turin 43
Helsinki 42
Cotonou 41
Rome 41
Dallas 40
Milan 40
Orem 40
Chennai 34
Montreal 34
Andover 31
Boardman 31
Dong Ket 30
Frankfurt am Main 30
Bremen 27
Nuremberg 27
Vercelli 26
Jakarta 25
Johannesburg 25
Brussels 24
Poplar 23
Redondo Beach 23
Falkenstein 22
Brno 21
Phoenix 21
Tokyo 21
Stockholm 20
Warsaw 20
Amsterdam 19
London 19
Toronto 19
Guangzhou 17
Haiphong 17
Houston 17
Chicago 15
Denver 15
Nanjing 15
Tianjin 15
Vienna 14
Ankara 13
Atlanta 13
Manchester 13
Zanjan 13
Da Nang 12
Hangzhou 12
Mumbai 12
Woodbridge 12
Mexico City 11
Turku 11
Boston 10
Brooklyn 10
Fairfield 10
Kunming 10
Monza 10
Nairobi 10
Seattle 10
Al Maḩallah al Kubrá 9
Hefei 9
Ottawa 9
Shanghai 9
Alessandria 8
Amman 8
Baghdad 8
Bari 8
Belo Horizonte 8
Cairo 8
Guayaquil 8
Melbourne 8
Norwalk 8
Quito 8
Tehran 8
The Dalles 8
Totale 6.217
Salva come PNG Salva come JPEG
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 400
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 263
Clinical and instrumental evaluation of Botulinum Toxin type A safety profile in post stroke spasticity rehabilitation treatment 242
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 204
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 193
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 168
A Rare Cause of Back Pain During Pregnancy and Lactation: Management and Treatment 162
Mid-term Psychiatric Outcomes of Patients Recovered From COVID-19 From an Italian Cohort of Hospitalized Patients 159
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 159
Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-Up 156
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. 156
Buccal hemineglect: is it useful to evaluate the differences between the two halves of the oral cavity for the multidisciplinary rehabilitative management of right brain stroke survivors? A cross-sectional study 156
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 152
Sarcopenic dysphagia: a narrative review 151
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 148
Can scoliosis lead to spinal cord ischaemia? Early diagnosis and rehabilitation: A paradigmatic case report and literature review 138
Post-COVID-19 sequelae are associated with sustained SARS-CoV-2-specific CD4+ immune responses 132
RIEDUCAZIONE DEL CAMMINO NEL MORBO DI PARKINSON: TRATTAMENTO ROBOTIZZATO VERSUS TRAINING SU TREADMILL. STUDIO RANDOMIZZATO CONTROLLATO 128
A new mutation in the CAVIN1/PTRF gene in two siblings with congenital generalized lipodystrophy type 4: case reports and review of the literature 124
Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature 124
Effects of Denosumab on Bone Turnover Markers compared to Zoledronic Acid in severe osteoporotic women: a randomized head to head study 123
Spinal Cord Injury as a Model of Bone-Muscle Interactions: Therapeutic Implications From in vitro and in vivo Studies 122
Heart Rate Variability modifications induced by high doses of incobotulinumtoxinA and onabotulinumtoxinA in hemiplegic chronic stroke patients: A single blind randomized controlled, crossover pilot study 119
ONCE YEARLY ZOLEDRONIC ACID AFTER 18 MONTHS OF PARATHYROID HORMONE (1-84) FOR SEVERE OSTEOPOROSIS 115
Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients 114
Accurate gait analysis in post-stroke patients using a single inertial measurement unit 112
MULTIMODAL ANALGESIA AND REHABILITATION PROTOCOL IN TOTAL KNEE REPLACEMENT: A PILOT STUDY 111
Abobotulinumtoxina and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis 111
Long-lasting consequences of Coronavirus disease 19 pneumonia: a systematic review 111
Administration of type a botulinum toxin after total hip replacement 109
Peripheral facial nerve palsy: how effective is rehabilitation? 108
Chronic stroke: an oxymoron or a challenge for rehabilitation? 107
Balance Rehabilitation through Robot-Assisted Gait Training in Post-Stroke Patients: A Systematic Review and Meta-Analysis 105
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke 104
The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study 103
Clinical characteristics that impact onabotulinumtoxinA treatment adherence in patients with spasticity from ASPIRE 103
Long-term effects of intra-articular oxygen-ozone therapy versus hyaluronic acid in older people affected by knee osteoarthritis: A randomized single-blind extension study 101
A single-blinded,randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot 100
Recovery from vegetative state of patients with a severe brain injury: a 4-year real-practice prospective cohort study 100
Evaluation of the safety profile of intra-articular treatment with Oxygen-Ozone therapy in knee arthrosis: controlled randomized study 100
Robotic gait training is not superior to conventional treadmill training in Parkinson's Disease: A single-blind randomized controlled trial 98
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 98
La valutazione dell’outcome nel percorso riabilitativo della protesi di ginocchio 97
Development of a patient-centered questionnaire for post-stroke spasticity assessment: a reliability study 97
ADHERENCE TO ONABOTULINUMTOXINA TREATMENT IN POST-STROKE PATIENTS WITH SPASTICITY FROM THE ASPIRE STUDY 95
What is the impact of robotic rehabilitation on balance and gait outcomes in people with multiple sclerosis? A systematic review of randomized control trials 95
Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study 94
The value of adding mirror therapy for upper limb motor recovery of subacute stroke patients: a randomized controlled trial. 94
Low back pain related to a sacral insufficiency fracture: Role of paravertebral oxygen-ozone therapy in a paradigmatic case of nociplastic pain 93
Efficacy of a Hip Flexion Assist Orthosis in Adults With Hemiparesis After Stroke. 92
Sonographic and clinical effects of botulinum toxin Type A combined with extracorporeal shock wave therapy on spastic muscles of children with cerebral palsy 92
Risk factors and outcome in falls 92
Optimization of transdisciplinary management of elderly with femur proximal extremity fracture: A patient-tailored plan from orthopaedics to rehabilitation 92
Adherence to onabotulinumtoxina treatment in multiple sclerosis patients with spasticity from the aspire study 91
Heart rate variability (hrv) modifications in adult hemiplegic patients after botulinum toxin type a (nt-201) injection. 90
Effects of robot-assisted gait training on postural instability in parkinson's disease: A systematic review 90
Once Yearly Zoledronic Acid After 18 months of Parathyroid Hormone (1-84) for Severe Osteoporosis 89
From paper to informatics: the Post Soft Care-App, an easy-to-use and fast tool to help therapists identify unmet needs in stroke patients 89
Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from the ASPIRE Study 89
High-Intensity Exercise Training Impact on Cardiorespiratory Fitness, Gait Ability, and Balance in Stroke Survivors: A Systematic Review and Meta-Analysis 88
BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach 88
Efficacy and safety of a hip flexion assist orthosis in adult hemiplegic stroke patients 87
Power Doppler Ultrasound Findings before and after Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Pilot Study on Pain Reduction and Neovascularization Effect 87
Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study 86
Differentiation among bio- and augmented- feedback in technologically assisted rehabilitation 86
Botulinum Toxin for Pain Relief in Cancer Patients: A Systematic Review of Randomized Controlled Trials 85
Robotic gait training is not superior to conventional treadmill training in parkinson disease: a single-blind randomized controlled trial. 85
Myostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary study 85
Triceps surae muscle characteristics in spastic hemiparetic stroke survivors treated with botulinum toxin type a: Clinical implications from ultrasonographic evaluation 85
Confronto randomizzato, controllato in doppio cieco tra casting e taping nel trattamento riabilitativo dopo tossina botulinica A 84
People with Spinal Cord Injury in Italy 84
ADHERENCE TO ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH SPASTICITY FROM THE ASPIRE STUDY 84
Rectus femoris characteristics in post stroke spasticity: Clinical implications from ultrasonographic evaluation 84
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 83
Post-stroke spasticity: follow-up and functional implications of chronic long-term treatment with botulinum toxin 82
ABOBOTULINUMTOXINA AND REHABILITATION VERSUS REHABILITATION ALONE IN POSTSTROKE SPASTICITY: AN ITALIAN COST-UTILITY ANALYSIS 82
Effects of Robot-Assisted Training for the Unaffected Arm in Patients with Hemiparetic Cerebral Palsy: A Proof-of-Concept Pilot Study 81
Multidimensional Effectiveness of Botulinum Toxin in Neuropathic Pain: A Systematic Review of Randomized Clinical Trials 81
Tolerability, Safety and Efficacy of a Specific Rehabilitation Treatment Protocol for Axillary Web Syndrome: An Observational Retrospective Study 81
Indicatori di qualità per la continuità delle cure in Medicina Riabilitativa 80
Ultrasonographic evaluation of botulinum toxin injection site for the medial approach to tibialis posterior muscle in chronic stroke patients with spastic equinovarus foot: An observational study 79
Once yearly Zoledronic Acid in Osteoporotic PD Patients compared to agematched osteoporotic post menopausal women 79
Development of new biomarkers in the prevention of lymphedema related to breast cancer: a multidisciplinary challenge 78
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke 78
Falls, fractures and bone density in Parkinson’s disease–a cross-sectional study 77
Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from ASPIRE 77
Is spasticity always the same? An observational study comparing the features of spastic equinus foot in patients with chronic stroke and multiple sclerosis 76
Post Soft Care: Italian implementation of a post-stroke checklist software for primary care and identification of unmet needs in community-dwelling patients 76
Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis 75
Does altering inclination alter effectiveness of treadmill training for gait impairment after stroke? A randomized controlled trial. 74
Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment 74
Ultrasound-guided injection of botulinum toxin type a for piriformis muscle syndrome: A case report and review of the literature 74
High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis 72
Different PTH response to oral peptone load and oral calcium load in patients with normocalcemic primary hyperparathyroidism, primary hyperparathyroidism, and healthy subjects 72
Valutazione comparativa di tre diversi protocolli riabilitativi post-inoculo di tossina botulinica A sull’ipertono spastico dell’arto inferiore 70
Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study 70
Management of stroke patients submitted to botulinum toxin type a therapy: A Delphi survey of an Italian expert panel of specialist injectors 70
Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals? 69
Management of spasticity with onabotulinumtoxinA: Practical guidance based on the Italian real-life post-stroke spasticity survey 68
Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity 68
Totale 10.704
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.729
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022864 0 13 148 67 57 54 52 52 62 61 119 179
2022/20231.644 129 79 74 35 91 147 52 87 810 18 68 54
2023/2024833 61 48 49 27 105 29 150 62 19 61 75 147
2024/20251.538 49 24 68 32 55 163 181 151 359 122 67 267
2025/20264.901 209 186 351 686 444 355 649 858 335 398 268 162
2026/2027532 205 327 0 0 0 0 0 0 0 0 0 0
Totale 12.072